Concord Biotech Ltd
NSE:CONCORDBIO
Wall Street
Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 448.4 INR with a low forecast of 1 181.7 INR and a high forecast of 1 764 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CONCORDBIO's stock price target?
Price Target
1 448.4
INR
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 448.4 INR with a low forecast of 1 181.7 INR and a high forecast of 1 764 INR.
What is Concord Biotech Ltd's Revenue forecast?
Projected CAGR
15%
For the last 4 years the compound annual growth rate for Concord Biotech Ltd's revenue is 18%. The projected CAGR for the next 3 years is 15%.
What is Concord Biotech Ltd's Operating Income forecast?
Projected CAGR
14%
For the last 4 years the compound annual growth rate for Concord Biotech Ltd's operating income is 11%. The projected CAGR for the next 3 years is 14%.
What is Concord Biotech Ltd's Net Income forecast?
Projected CAGR
13%
For the last 4 years the compound annual growth rate for Concord Biotech Ltd's net income is 12%. The projected CAGR for the next 3 years is 13%.
